 | • レポートコード：MRC2-11QY11259 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は心臓バイオマーカーのグローバル市場について調査・分析したレポートです。種類別（トロポニン、CK-MB、ナトリウム利尿ペプチド-BNP・NT-proBNP、ミオグロビン、その他）市場規模、用途別（急性冠症候群、心筋梗塞、うっ血性心不全、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別心臓バイオマーカーの競争状況、市場シェア ・世界の心臓バイオマーカー市場：種類別市場規模 2015年-2020年（トロポニン、CK-MB、ナトリウム利尿ペプチド-BNP・NT-proBNP、ミオグロビン、その他） ・世界の心臓バイオマーカー市場：種類別市場規模予測 2021年-2026年（トロポニン、CK-MB、ナトリウム利尿ペプチド-BNP・NT-proBNP、ミオグロビン、その他） ・世界の心臓バイオマーカー市場：用途別市場規模 2015年-2020年（急性冠症候群、心筋梗塞、うっ血性心不全、その他） ・世界の心臓バイオマーカー市場：用途別市場規模予測 2021年-2026年（急性冠症候群、心筋梗塞、うっ血性心不全、その他） ・北米の心臓バイオマーカー市場分析：米国、カナダ ・ヨーロッパの心臓バイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの心臓バイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の心臓バイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの心臓バイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Abbott、F. Hoffmann-La Roche、Advanced ImmunoChemical、AgPlus Diagnostics、BG Medicine、BioLegend、bioMérieux、Bio-Rad Laboratories、BODITECH MED ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.
The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years.
Market Analysis and Insights: Global Cardiac Biomarkers Market
The global Cardiac Biomarkers market size is projected to reach US$ 774.5 million by 2026, from US$ 704.2 million in 2020, at a CAGR of 9.2%% during 2021-2026.
Global Cardiac Biomarkers Scope and Market Size
Cardiac Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Abbott
F. Hoffmann-La Roche
Advanced ImmunoChemical
AgPlus Diagnostics
BG Medicine
BioLegend
bioMérieux
Bio-Rad Laboratories
BODITECH MED
Market segment by Type, the product can be split into
Troponin
CK-MB
Natriuretic Peptides – BNP and NT-proBNP
Myoglobin
Others
Market segment by Application, split into
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cardiac Biomarkers Revenue
1.4 Market by Type
1.4.1 Global Cardiac Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Troponin
1.4.3 CK-MB
1.4.4 Natriuretic Peptides – BNP and NT-proBNP
1.4.5 Myoglobin
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cardiac Biomarkers Market Share by Application: 2020 VS 2026
1.5.2 Acute Coronary Syndrome
1.5.3 Myocardial Infarction
1.5.4 Congestive Heart Failure
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Biomarkers Market Perspective (2015-2026)
2.2 Global Cardiac Biomarkers Growth Trends by Regions
2.2.1 Cardiac Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cardiac Biomarkers Historic Market Share by Regions (2015-2020)
2.2.3 Cardiac Biomarkers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cardiac Biomarkers Market Growth Strategy
2.3.6 Primary Interviews with Key Cardiac Biomarkers Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Biomarkers Players by Market Size
3.1.1 Global Top Cardiac Biomarkers Players by Revenue (2015-2020)
3.1.2 Global Cardiac Biomarkers Revenue Market Share by Players (2015-2020)
3.1.3 Global Cardiac Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cardiac Biomarkers Market Concentration Ratio
3.2.1 Global Cardiac Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Revenue in 2019
3.3 Cardiac Biomarkers Key Players Head office and Area Served
3.4 Key Players Cardiac Biomarkers Product Solution and Service
3.5 Date of Enter into Cardiac Biomarkers Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cardiac Biomarkers Historic Market Size by Type (2015-2020)
4.2 Global Cardiac Biomarkers Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cardiac Biomarkers Market Size by Application (2015-2020)
5.2 Global Cardiac Biomarkers Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cardiac Biomarkers Market Size (2015-2020)
6.2 Cardiac Biomarkers Key Players in North America (2019-2020)
6.3 North America Cardiac Biomarkers Market Size by Type (2015-2020)
6.4 North America Cardiac Biomarkers Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cardiac Biomarkers Market Size (2015-2020)
7.2 Cardiac Biomarkers Key Players in Europe (2019-2020)
7.3 Europe Cardiac Biomarkers Market Size by Type (2015-2020)
7.4 Europe Cardiac Biomarkers Market Size by Application (2015-2020)
8 China
8.1 China Cardiac Biomarkers Market Size (2015-2020)
8.2 Cardiac Biomarkers Key Players in China (2019-2020)
8.3 China Cardiac Biomarkers Market Size by Type (2015-2020)
8.4 China Cardiac Biomarkers Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cardiac Biomarkers Market Size (2015-2020)
9.2 Cardiac Biomarkers Key Players in Japan (2019-2020)
9.3 Japan Cardiac Biomarkers Market Size by Type (2015-2020)
9.4 Japan Cardiac Biomarkers Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cardiac Biomarkers Market Size (2015-2020)
10.2 Cardiac Biomarkers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cardiac Biomarkers Market Size by Type (2015-2020)
10.4 Southeast Asia Cardiac Biomarkers Market Size by Application (2015-2020)
11 India
11.1 India Cardiac Biomarkers Market Size (2015-2020)
11.2 Cardiac Biomarkers Key Players in India (2019-2020)
11.3 India Cardiac Biomarkers Market Size by Type (2015-2020)
11.4 India Cardiac Biomarkers Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cardiac Biomarkers Market Size (2015-2020)
12.2 Cardiac Biomarkers Key Players in Central & South America (2019-2020)
12.3 Central & South America Cardiac Biomarkers Market Size by Type (2015-2020)
12.4 Central & South America Cardiac Biomarkers Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Cardiac Biomarkers Introduction
13.1.4 Abbott Revenue in Cardiac Biomarkers Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Cardiac Biomarkers Introduction
13.2.4 Abbott Revenue in Cardiac Biomarkers Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 F. Hoffmann-La Roche
13.3.1 F. Hoffmann-La Roche Company Details
13.3.2 F. Hoffmann-La Roche Business Overview
13.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Introduction
13.3.4 F. Hoffmann-La Roche Revenue in Cardiac Biomarkers Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Recent Development
13.4 Advanced ImmunoChemical
13.4.1 Advanced ImmunoChemical Company Details
13.4.2 Advanced ImmunoChemical Business Overview
13.4.3 Advanced ImmunoChemical Cardiac Biomarkers Introduction
13.4.4 Advanced ImmunoChemical Revenue in Cardiac Biomarkers Business (2015-2020)
13.4.5 Advanced ImmunoChemical Recent Development
13.5 AgPlus Diagnostics
13.5.1 AgPlus Diagnostics Company Details
13.5.2 AgPlus Diagnostics Business Overview
13.5.3 AgPlus Diagnostics Cardiac Biomarkers Introduction
13.5.4 AgPlus Diagnostics Revenue in Cardiac Biomarkers Business (2015-2020)
13.5.5 AgPlus Diagnostics Recent Development
13.6 BG Medicine
13.6.1 BG Medicine Company Details
13.6.2 BG Medicine Business Overview
13.6.3 BG Medicine Cardiac Biomarkers Introduction
13.6.4 BG Medicine Revenue in Cardiac Biomarkers Business (2015-2020)
13.6.5 BG Medicine Recent Development
13.7 BioLegend
13.7.1 BioLegend Company Details
13.7.2 BioLegend Business Overview
13.7.3 BioLegend Cardiac Biomarkers Introduction
13.7.4 BioLegend Revenue in Cardiac Biomarkers Business (2015-2020)
13.7.5 BioLegend Recent Development
13.8 bioMérieux
13.8.1 bioMérieux Company Details
13.8.2 bioMérieux Business Overview
13.8.3 bioMérieux Cardiac Biomarkers Introduction
13.8.4 bioMérieux Revenue in Cardiac Biomarkers Business (2015-2020)
13.8.5 bioMérieux Recent Development
13.9 Bio-Rad Laboratories
13.9.1 Bio-Rad Laboratories Company Details
13.9.2 Bio-Rad Laboratories Business Overview
13.9.3 Bio-Rad Laboratories Cardiac Biomarkers Introduction
13.9.4 Bio-Rad Laboratories Revenue in Cardiac Biomarkers Business (2015-2020)
13.9.5 Bio-Rad Laboratories Recent Development
13.10 BODITECH MED
13.10.1 BODITECH MED Company Details
13.10.2 BODITECH MED Business Overview
13.10.3 BODITECH MED Cardiac Biomarkers Introduction
13.10.4 BODITECH MED Revenue in Cardiac Biomarkers Business (2015-2020)
13.10.5 BODITECH MED Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cardiac Biomarkers Key Market Segments
Table 2. Key Players Covered: Ranking by Cardiac Biomarkers Revenue
Table 3. Ranking of Global Top Cardiac Biomarkers Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cardiac Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Troponin
Table 6. Key Players of CK-MB
Table 7. Key Players of Natriuretic Peptides - BNP and NT-proBNP
Table 8. Key Players of Myoglobin
Table 9. Key Players of Others
Table 10. Global Cardiac Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Cardiac Biomarkers Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Cardiac Biomarkers Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Cardiac Biomarkers Market Share by Regions (2015-2020)
Table 14. Global Cardiac Biomarkers Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Cardiac Biomarkers Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Cardiac Biomarkers Market Growth Strategy
Table 20. Main Points Interviewed from Key Cardiac Biomarkers Players
Table 21. Global Cardiac Biomarkers Revenue by Players (2015-2020) (Million US$)
Table 22. Global Cardiac Biomarkers Market Share by Players (2015-2020)
Table 23. Global Top Cardiac Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Biomarkers as of 2019)
Table 24. Global Cardiac Biomarkers by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Cardiac Biomarkers Product Solution and Service
Table 27. Date of Enter into Cardiac Biomarkers Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cardiac Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 30. Global Cardiac Biomarkers Market Size Share by Type (2015-2020)
Table 31. Global Cardiac Biomarkers Revenue Market Share by Type (2021-2026)
Table 32. Global Cardiac Biomarkers Market Size Share by Application (2015-2020)
Table 33. Global Cardiac Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 34. Global Cardiac Biomarkers Market Size Share by Application (2021-2026)
Table 35. North America Key Players Cardiac Biomarkers Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Cardiac Biomarkers Market Share (2019-2020)
Table 37. North America Cardiac Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 38. North America Cardiac Biomarkers Market Share by Type (2015-2020)
Table 39. North America Cardiac Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 40. North America Cardiac Biomarkers Market Share by Application (2015-2020)
Table 41. Europe Key Players Cardiac Biomarkers Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Cardiac Biomarkers Market Share (2019-2020)
Table 43. Europe Cardiac Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Cardiac Biomarkers Market Share by Type (2015-2020)
Table 45. Europe Cardiac Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Cardiac Biomarkers Market Share by Application (2015-2020)
Table 47. China Key Players Cardiac Biomarkers Revenue (2019-2020) (Million US$)
Table 48. China Key Players Cardiac Biomarkers Market Share (2019-2020)
Table 49. China Cardiac Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 50. China Cardiac Biomarkers Market Share by Type (2015-2020)
Table 51. China Cardiac Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 52. China Cardiac Biomarkers Market Share by Application (2015-2020)
Table 53. Japan Key Players Cardiac Biomarkers Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Cardiac Biomarkers Market Share (2019-2020)
Table 55. Japan Cardiac Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Cardiac Biomarkers Market Share by Type (2015-2020)
Table 57. Japan Cardiac Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Cardiac Biomarkers Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Cardiac Biomarkers Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Cardiac Biomarkers Market Share (2019-2020)
Table 61. Southeast Asia Cardiac Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Cardiac Biomarkers Market Share by Type (2015-2020)
Table 63. Southeast Asia Cardiac Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Cardiac Biomarkers Market Share by Application (2015-2020)
Table 65. India Key Players Cardiac Biomarkers Revenue (2019-2020) (Million US$)
Table 66. India Key Players Cardiac Biomarkers Market Share (2019-2020)
Table 67. India Cardiac Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 68. India Cardiac Biomarkers Market Share by Type (2015-2020)
Table 69. India Cardiac Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 70. India Cardiac Biomarkers Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Cardiac Biomarkers Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Cardiac Biomarkers Market Share (2019-2020)
Table 73. Central & South America Cardiac Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Cardiac Biomarkers Market Share by Type (2015-2020)
Table 75. Central & South America Cardiac Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Cardiac Biomarkers Market Share by Application (2015-2020)
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Product
Table 80. Abbott Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 81. Abbott Recent Development
Table 82. Abbott Company Details
Table 83. Abbott Business Overview
Table 84. Abbott Product
Table 85. Abbott Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 86. Abbott Recent Development
Table 87. F. Hoffmann-La Roche Company Details
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Product
Table 90. F. Hoffmann-La Roche Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 91. F. Hoffmann-La Roche Recent Development
Table 92. Advanced ImmunoChemical Company Details
Table 93. Advanced ImmunoChemical Business Overview
Table 94. Advanced ImmunoChemical Product
Table 95. Advanced ImmunoChemical Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 96. Advanced ImmunoChemical Recent Development
Table 97. AgPlus Diagnostics Company Details
Table 98. AgPlus Diagnostics Business Overview
Table 99. AgPlus Diagnostics Product
Table 100. AgPlus Diagnostics Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 101. AgPlus Diagnostics Recent Development
Table 102. BG Medicine Company Details
Table 103. BG Medicine Business Overview
Table 104. BG Medicine Product
Table 105. BG Medicine Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 106. BG Medicine Recent Development
Table 107. BioLegend Company Details
Table 108. BioLegend Business Overview
Table 109. BioLegend Product
Table 110. BioLegend Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 111. BioLegend Recent Development
Table 112. bioMérieux Business Overview
Table 113. bioMérieux Product
Table 114. bioMérieux Company Details
Table 115. bioMérieux Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 116. bioMérieux Recent Development
Table 117. Bio-Rad Laboratories Company Details
Table 118. Bio-Rad Laboratories Business Overview
Table 119. Bio-Rad Laboratories Product
Table 120. Bio-Rad Laboratories Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 121. Bio-Rad Laboratories Recent Development
Table 122. BODITECH MED Company Details
Table 123. BODITECH MED Business Overview
Table 124. BODITECH MED Product
Table 125. BODITECH MED Revenue in Cardiac Biomarkers Business (2015-2020) (Million US$)
Table 126. BODITECH MED Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiac Biomarkers Market Share by Type: 2020 VS 2026
Figure 2. Troponin Features
Figure 3. CK-MB Features
Figure 4. Natriuretic Peptides - BNP and NT-proBNP Features
Figure 5. Myoglobin Features
Figure 6. Others Features
Figure 7. Global Cardiac Biomarkers Market Share by Application: 2020 VS 2026
Figure 8. Acute Coronary Syndrome Case Studies
Figure 9. Myocardial Infarction Case Studies
Figure 10. Congestive Heart Failure Case Studies
Figure 11. Others Case Studies
Figure 12. Cardiac Biomarkers Report Years Considered
Figure 13. Global Cardiac Biomarkers Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Cardiac Biomarkers Market Share by Regions: 2020 VS 2026
Figure 15. Global Cardiac Biomarkers Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Cardiac Biomarkers Market Share by Players in 2019
Figure 18. Global Top Cardiac Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Biomarkers as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Cardiac Biomarkers Revenue in 2019
Figure 20. North America Cardiac Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Cardiac Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Cardiac Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Cardiac Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Cardiac Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Cardiac Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Cardiac Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
心臓モニタリング・心臓リズムの世界市場（～2026年） Cardiac monitoring generally refers to continuous or intermittent monitoring of heart activity, generally by electrocardiography, with assessment of the patient's condition relative to their cardiac rhythm. Market Analysis and Insights: Global Cardiac Monitoring & Cardiac Rhythm Market The global Ca…- ゲノミクスバイオマーカーの世界市場（～2026年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…
- 予測バイオマーカーの世界市場（～2026年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…
- EPOバイオマーカーの世界市場（～2026年） Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Major factors contributing to the growth of the global EPO biomarkers market include increasing sede…
- 心臓イメージングの世界市場（～2026年） Cardiac imaging comprises intravascular ultrasound, echocardiogram and coronary catheterization. Intravascular ultrasound is an imaging technique carried out with the help of specially designed catheters attached to computerized ultrasound equipment to visualize the lumen and interior wall of blood …